Selected research
Industry Research
Cefuroxime Sodium Injection Industry Research Report 2026
Market perspective
The global Cefuroxime Sodium Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Cefuroxime Sodium Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Cefuroxime Sodium Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Cefuroxime Sodium Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Cefuroxime Sodium Injection include Aglobal Care, Hikma, Sagent, SteriMax, Teligent, Fresenius Kabi, Guangzhou Baiyunshan Tianxin Pharmaceutical, Sinopharm Weiqida Pharmaceutical and Harbin Pharmaceutical Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Cefuroxime Sodium Injection market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Cefuroxime Sodium Injection Market by Company
Aglobal Care
Hikma
Sagent
SteriMax
Teligent
Fresenius Kabi
Guangzhou Baiyunshan Tianxin Pharmaceutical
Sinopharm Weiqida Pharmaceutical
Harbin Pharmaceutical Group
Pfizer
Shanghai New Asia Pharmacetical
Weikang Pharmaceutical
Youcare Pharmaceutical Group
Cefuroxime Sodium Injection Segment by Type
0.25g/vial
0.5g/vial
0.75g/vial
1.5g/vial
Cefuroxime Sodium Injection Segment by Application
Hospital
Clinic
Others
Cefuroxime Sodium Injection Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cefuroxime Sodium Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cefuroxime Sodium Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cefuroxime Sodium Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Cefuroxime Sodium Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Cefuroxime Sodium Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Cefuroxime Sodium Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 0.25g/vial
- 0.5g/vial
- 0.75g/vial
- 1.5g/vial
Applications
- Hospital
- Clinic
- Others
Companies covered
- Aglobal Care
- Hikma
- Sagent
- SteriMax
- Teligent
- Fresenius Kabi
- Guangzhou Baiyunshan Tianxin Pharmaceutical
- Sinopharm Weiqida Pharmaceutical
- Harbin Pharmaceutical Group
- Pfizer
- Shanghai New Asia Pharmacetical
- Weikang Pharmaceutical
- Youcare Pharmaceutical Group
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Cefuroxime Sodium Injection Market Size (2021-2032)
- 2.2.2 Global Cefuroxime Sodium Injection Sales (2021-2032)
- 2.2.3 Global Cefuroxime Sodium Injection Market Average Price (2021-2032)
- 2.3 Cefuroxime Sodium Injection by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 0.25g/vial
- 2.3.3 0.5g/vial
- 2.3.4 0.75g/vial
- 2.3.5 1.5g/vial
- 2.4 Cefuroxime Sodium Injection by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Cefuroxime Sodium Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Cefuroxime Sodium Injection Sales (W Units) of Manufacturers (2021-2026)
- 3.3 Global Cefuroxime Sodium Injection Revenue of Manufacturers (2021-2026)
- 3.4 Global Cefuroxime Sodium Injection Average Price by Manufacturers (2021-2026)
- 3.5 Global Cefuroxime Sodium Injection Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Cefuroxime Sodium Injection, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Cefuroxime Sodium Injection, Product Type & Application
- 3.8 Global Manufacturers of Cefuroxime Sodium Injection, Established Date
- 3.9 Global Cefuroxime Sodium Injection Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Aglobal Care
- 4.1.1 Aglobal Care Company Information
- 4.1.2 Aglobal Care Business Overview
- 4.1.3 Aglobal Care Cefuroxime Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Aglobal Care Cefuroxime Sodium Injection Product Portfolio
- 4.1.5 Aglobal Care Recent Developments
- 4.2 Hikma
- 4.2.1 Hikma Company Information
- 4.2.2 Hikma Business Overview
- 4.2.3 Hikma Cefuroxime Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Hikma Cefuroxime Sodium Injection Product Portfolio
- 4.2.5 Hikma Recent Developments
- 4.3 Sagent
- 4.3.1 Sagent Company Information
- 4.3.2 Sagent Business Overview
- 4.3.3 Sagent Cefuroxime Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Sagent Cefuroxime Sodium Injection Product Portfolio
- 4.3.5 Sagent Recent Developments
- 4.4 SteriMax
- 4.4.1 SteriMax Company Information
- 4.4.2 SteriMax Business Overview
- 4.4.3 SteriMax Cefuroxime Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 SteriMax Cefuroxime Sodium Injection Product Portfolio
- 4.4.5 SteriMax Recent Developments
- 4.5 Teligent
- 4.5.1 Teligent Company Information
- 4.5.2 Teligent Business Overview
- 4.5.3 Teligent Cefuroxime Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Teligent Cefuroxime Sodium Injection Product Portfolio
- 4.5.5 Teligent Recent Developments
- 4.6 Fresenius Kabi
- 4.6.1 Fresenius Kabi Company Information
- 4.6.2 Fresenius Kabi Business Overview
- 4.6.3 Fresenius Kabi Cefuroxime Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Fresenius Kabi Cefuroxime Sodium Injection Product Portfolio
- 4.6.5 Fresenius Kabi Recent Developments
- 4.7 Guangzhou Baiyunshan Tianxin Pharmaceutical
- 4.7.1 Guangzhou Baiyunshan Tianxin Pharmaceutical Company Information
- 4.7.2 Guangzhou Baiyunshan Tianxin Pharmaceutical Business Overview
- 4.7.3 Guangzhou Baiyunshan Tianxin Pharmaceutical Cefuroxime Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Guangzhou Baiyunshan Tianxin Pharmaceutical Cefuroxime Sodium Injection Product Portfolio
- 4.7.5 Guangzhou Baiyunshan Tianxin Pharmaceutical Recent Developments
- 4.8 Sinopharm Weiqida Pharmaceutical
- 4.8.1 Sinopharm Weiqida Pharmaceutical Company Information
- 4.8.2 Sinopharm Weiqida Pharmaceutical Business Overview
- 4.8.3 Sinopharm Weiqida Pharmaceutical Cefuroxime Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Sinopharm Weiqida Pharmaceutical Cefuroxime Sodium Injection Product Portfolio
- 4.8.5 Sinopharm Weiqida Pharmaceutical Recent Developments
- 4.9 Harbin Pharmaceutical Group
- 4.9.1 Harbin Pharmaceutical Group Company Information
- 4.9.2 Harbin Pharmaceutical Group Business Overview
- 4.9.3 Harbin Pharmaceutical Group Cefuroxime Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Harbin Pharmaceutical Group Cefuroxime Sodium Injection Product Portfolio
- 4.9.5 Harbin Pharmaceutical Group Recent Developments
- 4.10 Pfizer
- 4.10.1 Pfizer Company Information
- 4.10.2 Pfizer Business Overview
- 4.10.3 Pfizer Cefuroxime Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Pfizer Cefuroxime Sodium Injection Product Portfolio
- 4.10.5 Pfizer Recent Developments
- 4.11 Shanghai New Asia Pharmacetical
- 4.11.1 Shanghai New Asia Pharmacetical Company Information
- 4.11.2 Shanghai New Asia Pharmacetical Business Overview
- 4.11.3 Shanghai New Asia Pharmacetical Cefuroxime Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Shanghai New Asia Pharmacetical Cefuroxime Sodium Injection Product Portfolio
- 4.11.5 Shanghai New Asia Pharmacetical Recent Developments
- 4.12 Weikang Pharmaceutical
- 4.12.1 Weikang Pharmaceutical Company Information
- 4.12.2 Weikang Pharmaceutical Business Overview
- 4.12.3 Weikang Pharmaceutical Cefuroxime Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Weikang Pharmaceutical Cefuroxime Sodium Injection Product Portfolio
- 4.12.5 Weikang Pharmaceutical Recent Developments
- 4.13 Youcare Pharmaceutical Group
- 4.13.1 Youcare Pharmaceutical Group Company Information
- 4.13.2 Youcare Pharmaceutical Group Business Overview
- 4.13.3 Youcare Pharmaceutical Group Cefuroxime Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Youcare Pharmaceutical Group Cefuroxime Sodium Injection Product Portfolio
- 4.13.5 Youcare Pharmaceutical Group Recent Developments
5 Global Cefuroxime Sodium Injection Market Scenario by Region
- 5.1 Global Cefuroxime Sodium Injection Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Cefuroxime Sodium Injection Sales by Region: 2021-2032
- 5.2.1 Global Cefuroxime Sodium Injection Sales by Region: 2021-2026
- 5.2.2 Global Cefuroxime Sodium Injection Sales by Region: 2027-2032
- 5.3 Global Cefuroxime Sodium Injection Revenue by Region: 2021-2032
- 5.3.1 Global Cefuroxime Sodium Injection Revenue by Region: 2021-2026
- 5.3.2 Global Cefuroxime Sodium Injection Revenue by Region: 2027-2032
- 5.4 North America Cefuroxime Sodium Injection Market Facts & Figures by Country
- 5.4.1 North America Cefuroxime Sodium Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Cefuroxime Sodium Injection Sales by Country (2021-2032)
- 5.4.3 North America Cefuroxime Sodium Injection Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Cefuroxime Sodium Injection Market Facts & Figures by Country
- 5.5.1 Europe Cefuroxime Sodium Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Cefuroxime Sodium Injection Sales by Country (2021-2032)
- 5.5.3 Europe Cefuroxime Sodium Injection Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Cefuroxime Sodium Injection Market Facts & Figures by Country
- 5.6.1 Asia Pacific Cefuroxime Sodium Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Cefuroxime Sodium Injection Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Cefuroxime Sodium Injection Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Cefuroxime Sodium Injection Market Facts & Figures by Country
- 5.7.1 South America Cefuroxime Sodium Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Cefuroxime Sodium Injection Sales by Country (2021-2032)
- 5.7.3 South America Cefuroxime Sodium Injection Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Cefuroxime Sodium Injection Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Cefuroxime Sodium Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Cefuroxime Sodium Injection Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Cefuroxime Sodium Injection Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Cefuroxime Sodium Injection Sales by Type (2021-2032)
- 6.1.1 Global Cefuroxime Sodium Injection Sales by Type (2021-2032) & (W Units)
- 6.1.2 Global Cefuroxime Sodium Injection Sales Market Share by Type (2021-2032)
- 6.2 Global Cefuroxime Sodium Injection Revenue by Type (2021-2032)
- 6.2.1 Global Cefuroxime Sodium Injection Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Cefuroxime Sodium Injection Revenue Market Share by Type (2021-2032)
- 6.3 Global Cefuroxime Sodium Injection Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Cefuroxime Sodium Injection Sales by Application (2021-2032)
- 7.1.1 Global Cefuroxime Sodium Injection Sales by Application (2021-2032) & (W Units)
- 7.1.2 Global Cefuroxime Sodium Injection Sales Market Share by Application (2021-2032)
- 7.2 Global Cefuroxime Sodium Injection Revenue by Application (2021-2032)
- 7.2.1 Global Cefuroxime Sodium Injection Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Cefuroxime Sodium Injection Revenue Market Share by Application (2021-2032)
- 7.3 Global Cefuroxime Sodium Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Cefuroxime Sodium Injection Value Chain Analysis
- 8.1.1 Cefuroxime Sodium Injection Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Cefuroxime Sodium Injection Production Mode & Process
- 8.2 Cefuroxime Sodium Injection Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Cefuroxime Sodium Injection Distributors
- 8.2.3 Cefuroxime Sodium Injection Customers
9 Global Cefuroxime Sodium Injection Analyzing Market Dynamics
- 9.1 Cefuroxime Sodium Injection Industry Trends
- 9.2 Cefuroxime Sodium Injection Industry Drivers
- 9.3 Cefuroxime Sodium Injection Industry Opportunities and Challenges
- 9.4 Cefuroxime Sodium Injection Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst